Literature DB >> 17161830

Chronic exposure to estrogen and tamoxifen regulates synaptophysin and phosphorylated cAMP response element-binding (CREB) protein expression in CA1 of ovariectomized rat hippocampus.

K Sharma1, Raj D Mehra, P Dhar, U Vij.   

Abstract

We report here the in vivo effects of estrogen (E2) on modulation of synaptic plasticity and the agonistic (estrogen-like) role of selective estrogen receptor modulator (SERM), tamoxifen (TAM) in the CA1 of the rat hippocampus. Effects on synaptophysin (SYP), a presynaptic vesicular protein, and phosphorylated cyclic AMP responsive element-binding (p-CREB) protein, a signal transduction pathway molecule, were studied using the ovariectomized (OVX) experimental rat model. Bilateral ovariectomy was performed on 40 rats and these were divided into 4 groups based on the treatment they received (at 2 weeks post-ovariectomy, a subcutaneous injection daily for 4 weeks) viz., OVX+E2 (0.1 mg/kg body weight), OVX+TAM (0.05 mg/kg body weight), OVX+vehicle and one group served as OVX control. An additional 10 animals served as the ovary intact control group. At the end of the treatment schedule, five animals/group were used for immunohistochemical staining of SYP and p-CREB using specific antibodies with peroxidase anti-peroxidase technique on paraformaldehyde-fixed cryostat sections. Protein estimation and Western blot analysis coupled with densitometric analysis (using gel-documentation system and image analysis software) were performed on unfixed hippocampus collected from rest of the five animals/group. Serum estradiol levels were estimated with radioimmunoassay prior to sacrifice. The results revealed that ovariectomy reduced SYP and p-CREB expression whereas E2 or TAM administration resulted in their upregulation. Serum estradiol levels of E2 administered animals were comparable with the ovary intact group whereas those of TAM administered group persisted in the range of OVX controls. To conclude, long-term estrogen therapy modulates the synaptic plasticity of hippocampal neurons and presumably, the agonist biocharacter of TAM as observed in the present investigations, may in the long run have a potential in the treatment and prevention of various estrogen-related disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17161830     DOI: 10.1016/j.brainres.2006.11.027

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

Review 1.  Tamoxifen and amphetamine abuse: Are there therapeutic possibilities?

Authors:  Sarah Mikelman; Natalie Mardirossian; Margaret E Gnegy
Journal:  J Chem Neuroanat       Date:  2016-08-30       Impact factor: 3.052

2.  Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.

Authors:  Peter J Winsauer; Catalin M Filipeanu; Evangeline M Bailey; Jerielle L Hulst; Jessie L Sutton
Journal:  Pharmacol Biochem Behav       Date:  2012-06-15       Impact factor: 3.533

3.  cAMP response element-binding protein (CREB) and nuclear factor κB mediate the tamoxifen-induced up-regulation of glutamate transporter 1 (GLT-1) in rat astrocytes.

Authors:  Pratap Karki; Anton Webb; Keisha Smith; Kyuwon Lee; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  J Biol Chem       Date:  2013-08-16       Impact factor: 5.157

4.  Long-term effects of estradiol replacement in the olfactory system.

Authors:  Britto P Nathan; Michael Tonsor; Robert G Struble
Journal:  Exp Neurol       Date:  2012-06-09       Impact factor: 5.330

5.  Estrogen receptor alpha and beta specific agonists regulate expression of synaptic proteins in rat hippocampus.

Authors:  Elizabeth M Waters; Katherine Mitterling; Joanna L Spencer; Sanoara Mazid; Bruce S McEwen; Teresa A Milner
Journal:  Brain Res       Date:  2009-07-09       Impact factor: 3.252

6.  Assay of Calcium Transients and Synapses in Rat Hippocampal Neurons by Kinetic Image Cytometry and High-Content Analysis: An In Vitro Model System for Postchemotherapy Cognitive Impairment.

Authors:  Patrick M McDonough; Natalie L Prigozhina; Ranor C B Basa; Jeffrey H Price
Journal:  Assay Drug Dev Technol       Date:  2017-07       Impact factor: 1.738

7.  Low doses of 17alpha-estradiol and 17beta-estradiol facilitate, whereas higher doses of estrone and 17alpha- and 17beta-estradiol impair, contextual fear conditioning in adult female rats.

Authors:  Cindy K Barha; Gemma L Dalton; Liisa Am Galea
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

8.  Antagonism of brain insulin-like growth factor-1 receptors blocks estradiol effects on memory and levels of hippocampal synaptic proteins in ovariectomized rats.

Authors:  Britta S Nelson; Rachel C Springer; Jill M Daniel
Journal:  Psychopharmacology (Berl)       Date:  2013-10-22       Impact factor: 4.530

Review 9.  The Impact of Estradiol on Neurogenesis and Cognitive Functions in Alzheimer's Disease.

Authors:  Sajad Sahab-Negah; Vahid Hajali; Hamid Reza Moradi; Ali Gorji
Journal:  Cell Mol Neurobiol       Date:  2019-09-09       Impact factor: 5.046

10.  Dihydrotestosterone activates CREB signaling in cultured hippocampal neurons.

Authors:  Thuy-Vi V Nguyen; Mingzhong Yao; Christian J Pike
Journal:  Brain Res       Date:  2009-08-31       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.